IIC
CRL icon

Integrated Investment Consultants’s Charles River Laboratories CRL Stock Holding History

Integrated Investment Consultants’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25
Closed -$3K – 283
2018
Q1 		$3K Buy
+25
New +$2.69K ﹤0.01% 771

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Integrated Investment Consultants's CRL Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Charles River Laboratories (CRL) in Q2 2018, closing a stake of 25 shares — an estimated $3K sold.

Integrated Investment Consultants first reported a position in CRL in Q1 2018 and held it in 1 quarter. The position peaked at $3K in Q1 2018. 348 funds tracked by Wall St. Rank hold CRL as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Charles River Laboratories position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 25 Charles River Laboratories shares in Q2 2018, an estimated $3K.
  • Integrated Investment Consultants first reported a position in Charles River Laboratories in Q1 2018 and held it in 1 quarter.
  • Integrated Investment Consultants's Charles River Laboratories position peaked at $3K in Q1 2018.
  • 348 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.